Dark

SLNO
Soleno Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Feb 27, 2026 3:59:58 PM EST

39.06USD+2.547%(+0.97)1,434,339

33.52Bid 44.56Ask 11.04Spread

Pre-market

Feb 27, 2026 9:28:30 AM EST

38.00USD-0.236%(-0.09)3,429

After-hours

Feb 27, 2026 4:49:30 PM EST

40.96USD+4.864%(+1.90)30,519

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

2.10B

CEO

Anish Bhatnagar

Headquarters

Redwood City, California, USA

Industry

Biotechnology

Next Earnings

Mar 11, 2026 (11d)

Last Split

Aug 26, 20221for15reverse

NEOG CEMI NYMX NTRP XLV

SLNO Stats

Avg. Vol. 10 Day

1,481,928

Avg. Vol. 30 Day

1,489,427

Employees

Market Cap

2,098,182,127

Shares Out.

53,710,025

On/Off Exchange

59%/41%

6 Month Beta

0.75

1 Year Beta

0.71

2 Year Beta

0.96

3 Year Beta

-0.16

52 Week Low

32.63

52 Week High

90.32

SMA50

43.24

SMA200

62.40

1 Week

-0.75%

1 Month

-9.49%

3 Month

-22.57%

6 Month

-42.28%

1 Year

-13.17%

2 Year

-25.38%

5 Year

+8.06%

Profile

soleno therapeutics, inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. the company is currently advancing its lead candidate, dccr, a once-daily oral tablet for the treatment of pws, into a phase iii clinical development program in early 2018.

SLNO Stock Summary

Soleno Therapeutics, Inc. Common Stock (NASDAQ:SLNO) stock price today is $39.06, and today's volume is 1,434,339. SLNO is up 2.547% today. The 30 day average volume is 1,489,427. SLNO market cap is 2.10B with 53,710,025 shares outstanding.

.dark-mode .gtTF5K{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .gtTF5K{ color: #333333; background-color: white; border: 2px solid #333333; }SLNOSoleno Therapeutics, Inc. Common Stockstock NASDAQ

SLNO Stock Summary

SLNO
Soleno Therapeutics, Inc. Common Stock
stock NASDAQ